Potential first ever targeted therapy designed for ‘untreatable’ childhood brain cancer

UK – Potential first ever targeted therapy designed for ‘untreatable’ childhood brain cancer

The international team of researchers have found that the new drug class can kill brain cancer cells with mutations in the ACVR1 gene and...
Lipidots : des cargos moléculaires pour la délivrance de médicaments

France – Lipidots : des cargos moléculaires pour la délivrance de médicaments

Nanoparticules lipidiques, les Lipidots sont des systèmes colloïdaux présentant un diamètre contrôlé de 50 à 120 nm, fabriqués à partir d’un cœur huileux (mélange...
Detailed guide regarding the monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the European Medicines Agency

Europe – New gene therapy to treat rare inherited blood condition

EMA has recommended granting a marketing authorisation in the European Union for a genetically modified product for beta-thalassaemia, a rare inherited blood condition that causes severe...
Scientists Gene-Edited Tequila Bacteria to Make Cannabinoids

Europe – Scientists Gene-Edited Tequila Bacteria to Make Cannabinoids

Lime Salt THC A German pharmaceutical company called Farmako just registered a patent for a process in which genetically modified tequila bacterium produce a range of biosynthetic cannabinoids —...
New ‘Trojan horse’ cancer treatment shows early promise

UK – New ‘Trojan horse’ cancer treatment shows early promise

The innovative new drug, called tisotumab vedotin (TV), releases a toxic substance to kill cancer cells from within. The results have been so positive...
NCCN: Updated NSCLC Guidelines Hone in on PD-L1 Testing

UK – Mapping of oesophageal cancer gene mutations leads to new drug targets

The news, which was published in Nature Genetics, comes from Cancer Research UK researchers at the University of Cambridge, who used whole genome sequencing and...
Lilly CEO on future cancer deals, gene therapy and CAR T-cells

USA – Lilly CEO on future cancer deals, gene therapy and CAR T-cells

Eli Lilly and Co remains in the hunt for cancer drugs even after announcing an $8 billion purchase of Loxo Oncology this week, but...
NCCN: Updated NSCLC Guidelines Hone in on PD-L1 Testing

UK – Immunotherapy extends the life of head and neck cancer patients

The study, by The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, found that the drug – MSD’s Keytruda (pembrolizumab) -...
How Can Nanotechnologies Aid Implantable Drug-Delivery Systems?

International – How Can Nanotechnologies Aid Implantable Drug-Delivery Systems?

Implantable technologies have come a long way over the years, and advancements in micro and nanotechnologies have helped device developers continue to push the...
‘Reprogrammed’ stem cells implanted into patient with Parkinson’s disease

International – ‘Reprogrammed’ stem cells implanted into patient with Parkinson’s disease

Japanese neurosurgeons have implanted ‘reprogrammed’ stem cells into the brain of a patient with Parkinson’s disease for the first time. The condition is only the...

NOS PROCHAINES FORMATIONS